Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Eye irritation

Currently viewing:

Administrative data

Endpoint:
eye irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2022

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 405 (Acute Eye Irritation / Corrosion)
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
Zinc dioctanoate
EC Number:
209-156-6
EC Name:
Zinc dioctanoate
Cas Number:
557-09-5
Molecular formula:
C16H30O4Zn
IUPAC Name:
zinc(II) octanoate
Constituent 2
Chemical structure
Reference substance name:
Zinc decanoate
EC Number:
235-909-3
EC Name:
Zinc decanoate
Molecular formula:
C10H20O2.1/2Zn
IUPAC Name:
zinc(II) decanoate
Constituent 3
Chemical structure
Reference substance name:
Zinc dilaurate
EC Number:
219-518-5
EC Name:
Zinc dilaurate
Cas Number:
2452-01-9
Molecular formula:
C12H24O2.1/2Zn
IUPAC Name:
zinc(II) dodecanoate
Constituent 4
Chemical structure
Reference substance name:
Zinc dimyristate
EC Number:
240-369-7
EC Name:
Zinc dimyristate
Cas Number:
16260-27-8
Molecular formula:
C28H54O4Zn
IUPAC Name:
zinc(II) tetradecanoate
Constituent 5
Chemical structure
Reference substance name:
Zinc dipalmitate
EC Number:
225-652-5
EC Name:
Zinc dipalmitate
Cas Number:
4991-47-3
Molecular formula:
C16H32O2.1/2Zn
IUPAC Name:
zinc(II) hexadecanoate
Constituent 6
Chemical structure
Reference substance name:
Zinc distearate
EC Number:
209-151-9
EC Name:
Zinc distearate
Cas Number:
557-05-1
Molecular formula:
C18H36O2.1/2Zn
IUPAC Name:
zinc(II) octadecanoate
Constituent 7
Chemical structure
Reference substance name:
Zinc dioleate
EC Number:
209-154-5
EC Name:
Zinc dioleate
Cas Number:
557-07-3
Molecular formula:
C18H34O2.1/2Zn
IUPAC Name:
zinc(II) 9-octadecenoate
Constituent 8
Chemical structure
Reference substance name:
Zinc dilinoleate
EC Number:
235-870-2
EC Name:
Zinc dilinoleate
Cas Number:
13014-44-3
Molecular formula:
C36H62O4Zn
IUPAC Name:
zinc(II) 9,12-octadecdienoate
Test material form:
solid: bulk

Test animals / tissue source

Species:
rabbit
Strain:
New Zealand White
Details on test animals or tissues and environmental conditions:
Species and strain : Sam: New Zealand White Rabbit
Microbiological grade : Specific Pathogen Free(SPF)
Sex : Female
Breeder : SAMTAKO BIO KOREA (105, Seorang-ro, Osan-si, Gyeonggi-do,
Republic of Korea, 18100)
Supplier : Yeongbio (388, Dunchon-daero, Jungwon-gu, Seongnam-si,
Gyeonggi-do, Republic of Korea, 13391)



Step Age (week old) Sex Number of animals A range of body weight(g)
At receipt 10 Female 4 1716.2~1887.8
At application 11 Female 3 2073.3~2190.2

Test system

Vehicle:
unchanged (no vehicle)
Controls:
yes, concurrent no treatment
Amount / concentration applied:
0.1 g of test substance was applied per eye
Duration of treatment / exposure:
1 hour
Observation period (in vivo):
72 hours
Number of animals or in vitro replicates:
3
Details on study design:
3.2.2 Method
5 minutes prior to application, 1~2 drops of 0.5 % Alcaine Eye Drops (proparacaine hydrochloride,
Alcon_Korea) was applied to each eye for local anesthesia.
The test substance was administered to the conjunctival sac of the right eye of each animal after gently pulling the lower lid away from the eyeball. The lids were then gently held together for about 1 second to prevent loss of test substance. The left eye remained untreated and served as a control.
3.2.2.1 Initial test (in vivo eye irritation/corrosion test using one animal)
One animal was used in the initial test and no serious eye damage/irreversible effect was observed at 1 hour after the test substance application.
3.2.2.2 Confirmatory test (in vivo eye irritation test with additional two animals)
In the initial test conducted on one animal, no serious eye damage/irreversible effect was observed at the application site after 1 hour. Therefore, a confirmatory test was conducted with two additional animals with the same procedure.

Results and discussion

In vivo

Resultsopen allclose all
Irritation parameter:
chemosis score
Basis:
animal #1
Time point:
24/48/72 h
Score:
ca. 1
Reversibility:
fully reversible within: 3 days
Irritation parameter:
chemosis score
Basis:
animal #2
Time point:
24/48/72 h
Score:
ca. 0.3
Reversibility:
fully reversible within: 3 days
Irritation parameter:
chemosis score
Basis:
animal #3
Time point:
24/48/72 h
Score:
ca. 0.3
Reversibility:
fully reversible within: 3 days
Irritation parameter:
conjunctivae score
Basis:
animal #1
Time point:
24/48/72 h
Score:
1
Max. score:
3
Reversibility:
fully reversible within: 3 days
Irritation parameter:
conjunctivae score
Basis:
animal #2
Time point:
24/48/72 h
Score:
0.3
Max. score:
3
Reversibility:
fully reversible within: 3 days
Irritation parameter:
conjunctivae score
Basis:
animal #3
Time point:
24/48/72 h
Score:
0.3
Max. score:
3
Reversibility:
fully reversible within: 3 days
Irritation parameter:
iris score
Basis:
animal #1
Time point:
24/48/72 h
Score:
0
Max. score:
2
Reversibility:
not specified
Remarks on result:
no indication of irritation
Irritation parameter:
iris score
Basis:
animal #2
Time point:
24/48/72 h
Score:
0
Max. score:
2
Reversibility:
not specified
Remarks on result:
no indication of irritation
Irritation parameter:
iris score
Basis:
animal #3
Time point:
24/48/72 h
Score:
0
Max. score:
2
Reversibility:
not specified
Remarks on result:
no indication of irritation
Irritation parameter:
cornea opacity score
Basis:
animal #1
Time point:
24/48/72 h
Score:
0
Max. score:
4
Reversibility:
not specified
Remarks on result:
no indication of irritation
Irritation parameter:
cornea opacity score
Basis:
animal #2
Time point:
24/48/72 h
Score:
0
Max. score:
4
Reversibility:
not specified
Remarks on result:
no indication of irritation
Irritation parameter:
cornea opacity score
Basis:
animal #3
Time point:
24/48/72 h
Score:
0
Max. score:
4
Reversibility:
not specified
Remarks on result:
no indication of irritation

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
This study was conducted to confirm the Globally Harmonized System of Classification and Labelling of Chemical (GHS) category through the calculation of Eye Irritation Scores based on the acute eye irritation and corrosivity of the test substance, Fatty acids, C8-18 and C18-unsatd., zinc salts, following a single application on the eyes of New Zealand White rabbits. Mortality, clinical signs and body weight changes, eye irritations and corrosivity were observed after the application.
Mortality and clinical signs related to the test substance were not observed in all animals.
Body weight changes related to the test substance were not observed in all animals.
Corrosion was not observed in all animals up to 72 hours after application of the test substance.
In the initial test and confirmatory tests, eye irritations of redness and swelling in conjunctiva were observed at 1(3 case), 24(3 case) and 48(1 case) hours after the application of the test substance. The effects listed above were fully reversible within 3 days of observation. The eye irritation scores of cornea, iris were calculated as “0.0” in all animals. The conjunctiva(redness) was calculated as “1.0”, “0.3” and “0.3”. The conjunctiva(swelling) was calculated as “1.0”, “0.3” and “0.3”.
Therefore, the test substance was considered to be non-irritants and the 21-day observation period required to establish reversibility was not applied.
The above results show that when applying the test substance, Fatty acids, C8-18 and C18-unsatd., zinc salts to under the conditions of this study, considered to be “Not classified” according to the GHS category.